US 9585941
Eye drop formulation
granted A61KA61K38/08A61K38/2292
Quick answer
US patent 9585941 (Eye drop formulation) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERX BIOPHARMACEUTICALS, INC.
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/08, A61K38/2292, A61K47/186, A61K9/0048